| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the p...
 
																	
 
																	
 
																	GPRK: 28% | Geopark shares are trading higher after Parex Resources submitted a proposal to acquire all outstanding shares of t...
 
																	
 
																	Intellia Therapeutics shares are tumbling in after-hours trading on Wednesday. Here's what you need to know.
 
																	
 
																	-SEC Filing
 
																	Wells Fargo analyst Yanan Zhu downgrades Intellia Therapeutics (NASDAQ:NTLA) from Overweight to Equal-Weight and lowers the ...